Celluminova specializes in developing new tools for stem cell research, including cancer stem cells. The patented biomarker p-HTMI is intended for live stem cell detection and visualization. It is currently not commercially available (see Pipeline for more information).
We specialize in developing new tools for stem cells research, including cancer stem cells.
The patented biomarker GlioStem® Surgery is intended for the detection and visualization of stem cell-like cells in brain tumors. Today, there are no products on the market that target stem-like cells in these tumors. The goal for GlioStem® Surgery is to be used during surgery to completely remove tumor tissue and thereby potentially lead to increased patient survival.
